PF-06266047
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-06266047, covering 2016-06-24 to 2016-06-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Evaluate the Safety, Tolerability, And Pharmacokinetics Of PF-06266047 In Healthy Adult Subjects [Phase 1]